Estrella Immunopharma (ESLA) Other Non-Current Assets (2023 - 2026)
Estrella Immunopharma (ESLA) posted quarterly Other Non-Current Assets of $1.5 million for Q1 2026, little changed year-over-year from $1.5 million in Q1 2025, and little changed quarter-over-quarter from $1.5 million in Q4 2025.
Estrella Immunopharma (ESLA) Other Non-Current Assets (2023 - 2026) Analysis & Trends
Estrella Immunopharma (ESLA) has reported Other Non-Current Assets for 4 consecutive years, with $1.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets changed 0.0% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (changed 0.0% YoY), while the FY2025 annual figure was $1.5 million, changed 0.0% from the prior year.
- Other Non-Current Assets steadied at $1.5 million in Q1 2026 per ESLA's latest filing, from $1.5 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $27.3 million in Q3 2023 and bottomed at $1.5 million in Q3 2024.
- Historically, Other Non-Current Assets has averaged $4.5 million across 4 years, with a median of $1.5 million in 2024.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets tumbled 94.52% — and 2025, when it changed 0.0%.
- Estrella Immunopharma's Other Non-Current Assets stood at $27.3 million in 2023, then sank by 94.52% to $1.5 million in 2024, then changed by 0.0% to $1.5 million in 2025, then changed by 0.0% to $1.5 million in 2026.
- Business Quant data shows ESLA's Other Non-Current Assets at $1.5 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | Estrella Immunopharma | 32.29 Mn | 32.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.50 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Sep 30, 2023 | 27.35 Mn |
| Jun 30, 2023 | 2.75 Mn |